Li J, Yu K, Pang D, Wang C, et al. Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial. J Clin Oncol 2020 Apr 10:JCO1902474. doi: 10.1200/JCO.19.02474.
PMID: 32275467